Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Published in: Journal of Inherited Metabolic Disease 6/2015

01-11-2015 | Editorial

Quo vadis: the re-definition of “inborn metabolic diseases”

Authors: Eva Morava, Shamima Rahman, Verena Peters, Matthias R. Baumgartner, Marc Patterson, Johannes Zschocke

Published in: Journal of Inherited Metabolic Disease | Issue 6/2015

Login to get access

Excerpt

How should we define or redefine inborn metabolic diseases (IMDs) in the era of genetic diagnostic revolution? Previously, it was relatively easy: IMDs were mostly inherited, and occasionally de novo, genetic disorders of the biosynthesis or breakdown of substances within specific pathways that were recognized by specific biochemical tests and sometimes treatable by metabolic intervention. Current challenges in the new era of emerging novel disorders are discussed and illustrated by examples of “classic” and novel-type IMDs. …
Literature
Carrillo-Carrasco N, Adams D, Venditti CP (2008) Disorders of intracellular cobalamin metabolism [updated 2013 Nov 21]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (eds) GeneReviews®. University of Washington, Seattle, 1993–2015
Caterino M, Pastore A, Strozziero MG, Di Giovamberardino G, Imperlini E et al (2015) The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans. J Inherit Metab Dis. PubMed
Freeze HH, Eklund EA, Ng BG, Patterson MC (2015) Neurological aspects of human glycosylation disorders. Annu Rev Neurosci. PubMed
Kanabus M, Shahni R, Saldanha JW, Murphy E, Plagnol V et al (2015) Bi-allelic CLPB mutations cause cataract, renal cysts, nephrocalcinosis and 3-methylglutaconic aciduria, a novel disorder of mitochondrial protein disaggregation. J Inherit Metab Dis 38(2):211–219CrossRefPubMed
Kornak U, Reynders E, Dimopoulou A, van Reeuwijk J, Fischer B et al (2008) Impaired glycosylation and cutis laxa caused bymutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet 40:32–34CrossRefPubMed
Lamari F, Mochel F, Saudubray JM (2015) An overview of inborn errors of complex lipid biosynthesis and remodelling. J Inherit Metab Dis 38:3–18CrossRefPubMed
Martinelli D, Travaglini L, Drouin CA, Ceballos-Picot I, Rizza T et al (2013) MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy. Brain 136:872–881CrossRefPubMed
Mayr JA, Haack TB, Graf E, Zimmermann FA, Wieland T et al (2012) Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am J Hum Genet 90:314–320PubMedCentralCrossRefPubMed
Morava E, Wong S, Lefeber D (2015) Disease severity and clinical outcome in phosphosgluco-mutase deficiency. J Inherit Metab Dis 38:207–209CrossRefPubMed
Pastore A, Martinelli D, Piemonte F, Tozzi G, Boenzi S et al (2014) Glutathione metabolism in cobalamindeficiency type C (cblC). J Inherit Metab Dis 37:125–129CrossRefPubMed
Schapira AH (2002) Primary and secondary defects of the mitochondrial respiratory chain. J Inherit Metab Dis 25:207–214CrossRefPubMed
Stockler S, Corvera S, Lambright D, Fogarty K, Nosova E et al (2014) Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking. Orphanet J Rare Dis 9:141PubMedCentralCrossRefPubMed
van de Ven S, Gardeitchik T, Kouwenberg D, Kluijtmans L, Wevers R, Morava E (2014) Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia. J Inherit Metab Dis 37:383–390PubMed
Wortmann SB, Vaz FM, Gardeitchik T, Vissers LE, Renkema GH et al (2012) Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 44:797–802CrossRefPubMed
Wortmann SB, Ziętkiewicz S, Kousi M, Szklarczyk R, Haack TB et al (2015) CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet 96:245–257PubMedCentralCrossRefPubMed
Metadata
Title
Quo vadis: the re-definition of “inborn metabolic diseases”
Authors
Eva Morava
Shamima Rahman
Verena Peters
Matthias R. Baumgartner
Marc Patterson
Johannes Zschocke
Publication date
01-11-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9893-x

Other articles of this Issue 6/2015

Journal of Inherited Metabolic Disease 6/2015 Go to the issue

Original Article

The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

Review

Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Original Article

Mutation of the iron-sulfur cluster assembly gene IBA57 causes fatal infantile leukodystrophy

Original Article

Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis

Original Article

Lack of phosphomannomutase 2 affects Xenopus laevis morphogenesis and the non-canonical Wnt5a/Ror2 signalling

Original Article

The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits